Journal of Pediatric Health Care
Volume 22, Issue 4 , Pages 211-217 , July 2008

Community-acquired Methicillin-resistant Staphylococcus aureus Infection in the Pediatric Population

  • Tsz-Yin So, PharmD

      Affiliations

    • Corresponding Author InformationCorrespondence: Tsz-Yin So, PharmD, University of North Carolina Hospitals, Department of Pharmacy, CB 7600, 101 Manning Dr, Chapel Hill, NC 27514
  • ,
  • Elizabeth Farrington, PharmD, FCCP, BCPS, FCCM

References 

  1. Braun L, Craft D, Williams R, Tuamokumo F, Ottolini M. Increasing clindamycin resistance among methicillin-resistance Staphylococcus aureus in 57 northeast United States military treatment facilities. Pediatric Infectious Disease Journal. 2005;24:622–626
  2. Centers for Disease Control and Prevention. (2005, February 3). Community-associated MRSA information for clinicians. Retrieved December 20, 2007, from http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca_clinicians.html
  3. David MZ, Crawford SE, Boyle-Vavra S, Hostetler MA, Kim DC, Daum RS. Contrasting pediatric and adult methicillin-resistant Staphylococcus aureus isolates. Emerging Infectious Diseases. 2006;12:631–637
  4. Ferrari CAM, Pirez GMC, Martinez AA, Algorta RG, Chamorro VF, Guala BMJ, et al. Etiology of community acquired pneumonia in inpatients children. Uruguay 1998-2004. Revista Chilena de Infectologia. 2007;24:40–47
  5. Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Archives of Internal Medicine. 2006;166:2138–2144
  6. Huang YC, Ho CF, Chen CJ, Su LH, Lin TY. Nasal carriage of methicillin-resistant Staphylococcus aureus in household contacts of children with community-acquired diseases in Taiwan. Pediatric Infectious Disease Journal. 2007;26:1066–1068
  7. King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Annals of Internal Medicine. 2006;144:309–317
  8. Ladhani S, Garbash M. Staphylococcal skin infections in children. Pediatric Drugs. 2005;7:77–102
  9. Lamaro-Cardoso J, Castanheira M, de Oliveira RM, e Silva SA, Pignatari AC, Mendes RE, et al. Carriage of methicillin-resistant Staphylococcus aureus in children in Brazil. Diagnostic Microbiology and Infectious Disease. 2007;57:467–470
  10. Le J, Lieberman JM. Management of community-associated methicillin-resistant Staphylococcus aureus infections in children. Pharmacotherapy. 2006;26:1758–1770
  11. Lexi-Comp. (2008, January 19). Retrieved March 23, 2008, from http://online.lexi.com/crlsql/servlet/crlonline
  12. Marcinak JF, Frank AL. Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children. Current Opinion in Infectious Diseases. 2003;16:265–269
  13. Ochoa TJ, Mohr J, Wanger A, Murphy JR, Heresi GP. Community-associated methicillin-resistant Staphylococcus aureus in pediatric patients. Emerging Infectious Diseases. 2005;11:966–968
  14. Paintsil E. Pediatric community-acquired methicillin-resistant Staphylococcus aureus infection and colonization: trends and management. Current Opinion in Pediatrics. 2007;19:75–82
  15. Zaoutis TE, Toltzis P, Chu J, Abrams T, Dul M, Kim J, et al. Clinical and molecular epidemiology of community-acquired methicillin-resistant Staphylococcus aureus infections among children with risk factors for healthcare-associated infection. Pediatric Infectious Disease Journal. 2006;25:343–348

PII: S0891-5245(08)00125-9

doi: 10.1016/j.pedhc.2008.04.010

Journal of Pediatric Health Care
Volume 22, Issue 4 , Pages 211-217 , July 2008